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Abstract
In order to define the molecular mechanisms regulating the specification and differentiation of pancreatic b-islet cells, we
investigated the effect of upregulating Pdx1 and Ngn3 during the differentiation of the b-islet-like cells from murine
embryonic stem (ES) cell-derived activin induced-endoderm. Induced overexpression of Pdx1 resulted in a significant
upregulation of insulin (Ins1 and Ins2), and other pancreas-related genes. To enhance the developmental progression from
the pancreatic bud to the formation of the endocrine lineages, we induced the overexpression express of Ngn3 together
with Pdx1. This combination dramatically increased the level and timing of maximal Ins1 mRNA expression to approximately
100% of that found in the bTC6 insulinoma cell line. Insulin protein and C-peptide expression was confirmed by
immunohistochemistry staining. These inductive effects were restricted to c-kit
+ endoderm enriched EB-derived populations
suggesting that Pdx1/Ngn3 functions after the specification of pancreatic endoderm. Although insulin secretion was
stimulated by various insulin secretagogues, these cells had only limited glucose response. Microarray analysis was used to
evaluate the expression of a broad spectrum of pancreatic endocrine cell-related genes as well as genes associated with
glucose responses. Taken together, these findings demonstrate the utility of manipulating Pdx1 and Ngn3 expression in a
stage-specific manner as an important new strategy for the efficient generation of functionally immature insulin-producing
b-islet cells from ES cells.
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Introduction
Islet transplantation has been shown to be useful in the
treatment of patients with type 1 diabetes, even resulting in insulin
independence [1,2]. However, this therapeutic approach is limited
by a shortage of transplantable islets. Consequently, other
potential sources of b-islet cells are currently being sought. Two
such alternatives are pancreatic duct cells and endocrine
progenitor cells [3–5]. Another possible source of insulin-
producing cells are pluripotent stem cells (ES or iPS), which are
self-renewing and retain the potential to differentiate into all three
germ layers [6,7]. This makes pluripotent stem cells a very useful
experimental model to study pancreatic development, and the
pancreatic cells that develop from these stem cells are a potential
source of islet cells for diabetes therapy.
Within the embryo, the pancreas derives from epithelium of the
foregut endoderm, which forms dorsal and ventral buds on
approximately day 9 of murine embryonic development [8,9].
During pancreas and b-islet cell development, the transcription
factor Pdx1 is expressed in the embryonic gut epithelium that will
later give rise to the dorsal and ventral pancreas [10–12]. The fact
that Pdx1 is a master gene for early pancreatic development is
demonstrated by the pancreatic agenesis occurring after bud
formation in mice lacking functional Pdx1 [13]. In addition,
ectopic expression of Pdx1 induces pancreatic budding from the
gut epithelium [14].
After pancreatic bud formation, another transcription factor,
Neurogenin 3 (Ngn3), plays a critical role in the formation of
pancreatic endocrine precursors. Notably, mice lacking Ngn3 also
lack the four pancreatic endocrine cells, which produce insulin
(Ins), glucagon (Gcg), somatostatin (Sst) and pancreatic polypep-
tide (Ppy) [15]. Moreover, lineage tracking studies using the Cre-
ER loxP system have shown that, after Pdx1 expression, Ngn3-
positive cells give rise to all four endocrine cell types [16],
suggesting that Ngn3 is expressed in the early endocrine
progenitor cells that give rise to, and presumably contributes to
the differentiation of, the four endocrine cell types. In addition,
targeted disruption in mice has shown that various other
transcriptional factors, including Pax4 [17], NeuroD [18],
Nkx2.2 [19] and Nkx6.1 [20], are also critical for differentiation
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factors must be expressed in a correct temporal order for
appropriate lineage specification and differentiation of gut
endoderm, pancreatic progenitors, endocrine progenitors and,
finally, pancreatic b-islet cells.
We previously established a protocol for the activin-induced
development of definitive endoderm during mouse ES cell
differentiation [21,22]. Similarly, D’Amour et al. reported that
pancreatic hormone-expressing endocrine cells can be differenti-
ated from human ES cell-derived endoderm through induction
with activin [23,24]. They further showed that the soluble growth
factors that participate in pancreatic development during human
embryonic development can mimic that process during human ES
cell differentiation in vitro [23,24].
In the present study, we evaluated the transcriptional regulation
that is critical for induction of b-islet cell differentiation from
mouse ES cell-derived endoderm. Previous study have demon-
strated that biphasic induction of Pdx1 induce insulin producing
cells in ES cell derived endoderm [25]. In this study, we show that
temporally controlled expression of Pdx1 and Ngn3 induces
pancreatic endocrine genes, various b-islet cell-related transcrip-
tion factors, including Pax4, Pax6, Isl1 and Nkx2.2, and efficiently
yields a high frequency of b-islet cells that express very high levels
of insulin. Lastly, although these b-islet cells appropriately process
and secrete insulin and C-peptide protein in response to various
insulin secretagogues, they do not demonstrate adult levels of
glucose-controlled insulin secretion.
Results
Pdx-1 induces insulin mRNA expression in activin-
induced endoderm embryoid bodies (EBs)
It is well known that Pdx1 is a master gene for early pancreatic
development from the gut tube, and previous protocols resulted in
very modest levels of Pdx1. Therefore, we engineered ES cells with
a doxycycline (Dox)-inducible Pdx1 (‘‘tet-pdx1 ES cells’’) expres-
sion vector to evaluate the effect of temporal control of Pdx1
upregulation. For these studies we used Protocol #1 (‘‘SP
protocol’’) as previously described [21]. Pdx1 expression was
induced in the cells by adding Dox (1 mg/ml) to the EB cultures
between days 6 and 20.
Dox-induced Pdx1 expression was confirmed by reverse
transcription-polymerase chain reaction (RT-PCR) performed on
days 6, 10, 14, 17 and 20 of differentiation (Fig. 1A). Overex-
pression of Pdx1 protein resulted in an upregulation of Ins1 and
Ins2 mRNA expression seen as early as day 10 for Ins1 and day 14
for Ins2, and they reached maximum levels at day 17 (Fig. 1A).
Ins1 is express only in pancreas, whereas Ins2 is expressed in both
pancreas and brain [26,27]. Quantitative PCR analysis revealed
that the normalized (see Methods) level of Ins1 expression at day
d20 represents 0.08% of the expression seen in the bTC6
insulinoma cell line (ATCC CRL-11506) (Fig. 1B). For compar-
ison, normalized Ins1 mRNA levels in mouse pancreatic islets are
approximately 140% of the bTC6 levels (data not shown).
Co-expression of Ngn3 with Pdx-1 increases insulin mRNA
expression in activin-induced endoderm EBs
Because levels of Ins1 mRNA are much lower in the ES
differentiated cells than in bTC6 cells, and the fact that Ngn3 levels
in these cultures is very low (data not shown), we next evaluated
the effects of Ngn3 and other factors to improve b-islet cell
differentiation and insulin expression. To do this, we transiently
expressed target genes by cloning them into pIRES2-EGFP and
electroporating the vectors into cells isolated from day 6 EBs under
Protocol #1. Subsequent FACS analysis confirmed that this
method produced about 42% GFP-positive cells 2 days after
electroporation (Fig. 1C). Using this system, we transiently
overexpressed Pax4, Nkx6.1 and Ngn3, all of which are known to
be important for b-islet cell specification, in cells with Dox-induced
Pdx1 expression. RT-PCR or real time PCR on day 9 showed that
all genes were expressed 3 days after electroporation and that only
Ngn3 induced Ins1 expression at significant levels (Fig. 1D). The
transient upregulation of Ngn3 resulted in a significant increase
above Pdx1 alone in the normalized expression of Ins1 to
approximately 0.07% of the bTC6 level, which was dependent
on the Dox-induced upregulation of Pdx1 (data not shown). It is
important to note that this transient Ngn3 expression, together
with Pdx1, dramatically accelerated Ins1 mRNA expression, and
significantly higher levels of Ins1 (data not shown).
To further characterize this effect, we generated Ainv cells
capable of stable Dox-induced co-expression of Pdx1 and Ngn3 using
a bi-cistronic Pdx1-IRES-Ngn3 inducible expression construct.
When Dox was added on day 6, normalized levels of Ins1 mRNA
increased to a maximum level by day 9, which was approximately
1.5% of the levels seen in bTC6 (Fig. 1E). Similarly, Gcg expression
appeared on day 9 after upregulating both Pdx1 and Ngn3 (Fig. 1F).
These data are consistent with the transient expression data
presented in Figure 1D and suggest that stable co-expression of
Ngn3 and Pdx1 increases Ins1 mRNA levels about 20-fold higher
than overexpression Pdx1 alone, shortens the time to peak Ins1
mRNAlevelsfrom 20 days to 9 days (compareFig.1B with1E),and
results in the differentiation of a-cell production of glucagon.
Suspension culture in the presence of BMP4 enhances
Ins1 gene expression induced by Pdx1 and Ngn3
Recently, Gouon-Evans et al. showed that BMP4 is required for
hepatic differentiation of mouse ES cell-derived definitive endo-
derm [22]. The recent work of Wandzioch and Zaret also actually
shows that in the mouse embryo, BMP is required at a later time
point for pancreas specification compared to liver specification[28].
They show that an early activation with BMP4 would block pdx1
expression from endoderm (but induces alb expression), while is
necessary few hours later to induce pdx1. These results suggested a
dynamic role of BMP4 to induce liver and pancreatic differentiation
[28]. In this study, we evaluated the effect of BMP4 on the
differentiation of insulin producing cells from mouse ES cell-derived
definitive endoderm. After two passages on gelatin, dissociated tet-
pdx1/ngn3 ES cells were cultured for 2 days as EBs using Protocol
#2 in serum-free differentiation medium, as previously described
(‘‘SFD protocol’’) [22]. Activin A was then added from day 2 to day
4 to induce definitive endoderm, and on day 4, the effects of Dox
and BMP4 were evaluated. Without Dox, no Ins1 mRNA was
detected on day 6 or 9 (data not shown). When Dox was added on
day 4 to induce Pdx1 and Ngn3expression, normalized Ins1 mRNA
levelsreached 0.6% onday 6and3.1%onday9 ofdifferentiationof
bTC6 levels (Fig. 2A). It was noticed that some of the day 6 EBs
which were replated on gelatin coated 6 well plates attached on the
plateandformeda monolayer,whileothersremainedinsuspension.
The floating EBs were transferred to a low-cluster dish (12–24 well
plate, Corning) on day 7. On day 9, all cells remained floating in
these cultures and the Ins1 mRNA levels were significantly higher in
these cells than in the monolayer cells cultured on the gelatin coated
dishes, reaching 4.9% of bTC6 levels (Fig. 2B). In a subsequent
experiment, Dox was present continuously from day 4 and EBs
were cultured with BMP4, bFGF and activin A from day 4 to day 6
and then transferred to low-cluster dishes (12- or 24-well) until day
16. Under these conditions expression of Ins1 and Ins2 mRNA
continued to increase until day 16, reaching 13.2% and 8.2% of
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Protocol #2 with BMP4 and culturing in suspension increased
Ins1 mRNA levels about 10-fold, as compared to the Protocol #1.
Insulin-expressing pancreatic cells are derived from a
CXCR4/c-kit
+/+ population
We previously showed that cells positive for both CXCR4 and
c-kit give rise to definitive endoderm and hepatocytes [22]. Here
we tested whether this same population also gives rise to
pancreatic cells. EBs were cultured using Protocol #2 for 4 days,
after which they were trypsinized to obtain suspensions of single
cells, and immunostaining was then used to detect CXCR4 and c-
kit. The stained cells were sorted and the CXCR4 and c-kit double
positive and double negative populations were reaggregated for 2
days using Protocol #2. When reaggregated EBs were replated on
gelatin-coated dishes on day 6 using Protocol #2, most double
negative CXCR4/c-kit
(/) cells attached to the dishes, whereas most
double positive CXCR4/c-kit
(+/+) endodermal cells did not attach
but remained in suspension as EBs. On day 9, no Ins1 mRNA was
detected in the adherent monolayer of CXCR4/c-kit
(/) cells,
Figure 1. Pancreatic differentiation induced by Pdx1 and Ngn3. (A, B) Tet-pdx1 ES cells were cultured according to Protocol #1. Pdx1
expressions were induced with Dox (closed circle, Dox
+) or without (open square, Dox
2) for 6 to 20 days. A) Gene expression was analyzed by RT-PCR.
B) Ins1 mRNA levels were quantified by real time PCR and normalized to 18S mRNA levels. (C, D) EBs were differentiated for 6 days according to
Protocol #1 and trypsinized to make single cell suspensions. The cells were electroporated with the pIRES2-EGFP vector and then reaggregated for
2–3 additional days with Dox. C) At day 8 (2 days with Dox), EGFP was evaluated by FACS. D) pIRES2 vectors, constructed to express GFP, Pax4, Nkx6.1
or Ngn3, were electroporated into day 6 EBs and allowed to reaggregate. At day 9, EBs were harvested and gene expression was analyzed by RT-PCR.
(E, F) Tet-pdx1/ngn3 ES cells were cultured according to Protocol #1. Pdx1 and Ngn3 expression was induced with Dox (closed circle, Dox
+)o r
without (open square, Dox
2) at day 6 and harvested at the indicated time points. E) Ins1 mRNA levels were quantified by real time PCR and
normalized to levels in bTC6 as described in the Methods. F) Gene expression was analyzed by RT-PCR. Note, for the day 6 sample, the cells were
exposed to Dox for only 1 hour before the samples were harvested.
doi:10.1371/journal.pone.0024058.g001
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(+/+) cells
were more than 2-fold higher than in pre-sorted EBs (Fig. 2D).
This suggests that, like ES-derived hepatocyte-like cells, ES-
derived pancreas-like cells are derived from a CXCR4/c-kit
(+/+)
definitive endoderm population, which differentiates more effi-
ciently in a 3-dimensional non-adherent structure as opposed to a
2D monolayer. Interestingly, these isolated endodermal cells
produced small EBs that did not grow well. We could not
continue to culture the 3-deminsional non-adherent structures
beyond day 9. They did not grow well and tended to disrupt. We
suspect that there may be a requirement for a non-endodermal cell
for maintenance and growth of the pancreas cells under these
conditions.
Pancreas-related genes induced by Pdx1 and Ngn3 under
Protocol #2 with BMP4
RT-PCRwasused toevaluatetheexpressionofIns1 and a variety
of pancreas-related genes from cells cultured in suspension with
BMP4 under Protocol #2. These studies revealed that overexpres-
sion of Pdx1 and Ngn3 induced the following genes: 1) secretory
pancreatic endocrine genes (Ins1, Ins2, Gcg, Sst, Ppy and Ghrl),
incretin hormone related-genes (Gip and Glp1r), and exocrine genes
(Amy and Ela) (Fig. 3A); 2) genes related to insulin secretion and
insulin processing (Pcsk1, Pcsk2 and Chga), genes related to glucose
sensing (Glut2 and Gck), and genes related to potassium ion channels
(Kir6.2) (Fig. 3B); and 3) pancreas-related transcription factor genes
(Ptfa1, Pax4, Pax6, neuroD, Isl1, Nkx2.2, MafA and Hex) (Fig. 3C). It is
interesting to note that the liver- and intestine-related genes Alb, Afp
and Fabp2 were suppressed by Dox induction, as was Shh,a n
inhibitor of pancreatic endoderm (Fig. 3A).
Microarray analysis of genes downstream of Pdx1 and
Ngn3
For a more in-depth analysis of the impact of Pdx1 and Ngn3
expression on lineage development, we carried out a microarray
analysis to identify genes activated downstream of Pdx1 and Ngn3.
Figure 2. BMP4 and 3D non-adherent culture improves Ins1 expression. Tet-pdx1/ngn3 ES cells were cultured according to Protocol #2.
Pdx1 and Ngn3 were induced with or without Dox starting at day 4, and cells were harvested at the indicated time points. (A–D) insulin and 18S
mRNA levels were quantified by real time PCR and normalized to levels seen in bTC6 as described in the Methods. A) Day 4 EBs were trypsinized and
reaggregated with BMP4 (closed circles) or without (open squares). EBs were harvested at day 6 and 9. B) Day 4 EBs were trypsinized and
reaggregated with BMP4. At day 6, EBs were replated on gelatin coated dishes and floating EBs were transferred to low-cluster dishes at day 7.
Attached monolayer EBs (open bar) and floating EBs (closed bar) were harvested at day 9. (C) Floating EBs were cultured according to Protocol #2,
with BMP4, and with Dox (circles) or without Dox (open squares). Ins1 (black circles) or Ins2 (white circles) mRNA levels were quantified by real time
PCR and normalized to levels in bTC6 at the times indicated. (D) CXCR4/c-kit double negative (2/2) or double positive (+/+) cells were isolated by
FACS from 4 days EBs, reaggregated for two days, and then replated on gelatin coated plates according to Protocol #2, with BMP4. Floating or
attached EBs were harvested at day 9 from the following populations: pre-sorted cells (‘‘Pre’’); CXCR4/c-kit double negative (‘‘2/2’’); and CXCR4/c-kit
double positive (‘‘+/+’’). These groups were cultured either as non-adherent EBs (‘‘float’’) or as attached monolayer cells (‘‘mono’’), as indicated.
doi:10.1371/journal.pone.0024058.g002
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ngn3 Ainv cells cultured under Protocol #2, with BMP4 and
floating non-adherent conditions for 13 days, were evaluated by
microarray analysis and compared to gene expression of E15.5
embryonic pancreas, adult islet cells, and bTC6 cells. All primary
microarray data are available at http://www.ncbi.nlm.nih.gov/
geo/ under accession numbers GSM586113-122 and
GSM312098-127.
With this analysis we found that other pancreas-related genes
are upregulated by Pdx1 and Ngn3 (supplemental Table S3).
These genes were categorized based on gene ontology analysis as
follows: 1) ‘‘Extracellular’’ secretory proteins including: A)
pancreatic endocrine and exocrine genes (Ins1, Sst, Gcg, Ppy, Ghrl
and Cpa); B) genes related to insulin secretion (Scg, Chga, Pcsk); and
C) enteroendocrine genes (Gip, Cck, Pyy, Sct and Ghrl); 2) ‘‘Nuclear’’
transcription factors, including b-islet cell-related transcription
factors (Pax6, Insm1, Neurod1, Nkx2.2, Isl1, Hhex, Nkx6.1 and Pax4)
and a-cell-related transcription factors (Arx, Irx2); and 3)
‘‘Miscellaneous’’, which includes genes whose direct functional
role in b-islet differentiation is not clear, i.e. cytoskeletal/
membrane and cytoplasmic/signaling genes. The upregulation
of some of the Miscellaneous genes, e.g. (Dcx, Stmn2 and Tubb3), is
consistent with an earlier study evaluating novel Ngn3-related
genes in mouse ES cells [29]. To determine the time course of the
expression of these genes under Protocol #2 culture conditions,
microarray analyses were performed on days 4, 6 and 13. Selected
pancreas-related genes (Ins1, Gip, neurod1, Sst, Scg3, Insm1, Gcg,
Pax6, and Arx) indicate that there is a significant upregulation of
these genes after day 6, suggesting differentiation from endoderm
to a pancreatic fate during this time period (Supplemental Fig. S1).
Depletion of N2 and RA increases Ins1 mRNA levels
Protocol #2 used in this study was originally established for
hepatocyte differentiation from mouse ES cells [22]. To optimize
b-islet cell differentiation we tested whether N2 or RA,
supplements that we used for differentiating hepatocytes, were
useful for pancreatic EB differentiation and Ins1 expression. We
explored this with Protocol #3, which is identical to Protocol #2
except that N2 and B27 (2RA, i.e.-without RA), were not used at
any time during the culture, and after day 6 the cells were grown
in suspension (see Supplemental Table S1). We found that the
highest Ins1 expression was obtained when both N2 and RA were
removed from the protocol, which resulted in an increased Ins1
mRNA level to 23% of that in bTC6 cells (Fig. 4A). FACS analyses
indicated that approximately 27% of Dox-stimulated EBs cultured
under Protocol #3 for 18 days showed cytoplasmic insulin staining
(Fig. 4B). This insulin expression was dependent on the expression
Figure 3. Time course of pancreas-related gene expression. Tet-pdx1/ngn3 ES cells were cultured according to Protocol #2, with BMP4. Pdx1
and Ngn3 were induced with Dox (Dox
+) or without (Dox
2) at day 4, and gene expression was analyzed from day 9–16 by RT-PCR and compared to
bTC6 mRNA. (A) Secretory proteins and liver/intestine related-genes. (B) Insulin processing genes and glucose sensing genes. (C) Pancreas related-
transcriptional factors.
doi:10.1371/journal.pone.0024058.g003
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Dox were positive for insulin (Fig. 4B).
C-peptide is secreted from EBs induced by Pdx-1 and
Ngn3
To evaluate pancreatic hormone secretion, pancreatic EBs were
cultured for 18 days under Protocol #3, after which the medium
was replaced with fresh Protocol #3 medium (IMDM,F12,BSA,-
B27(2RA)) for 24 hours. We then assayed the supernatant for C-
peptide, glucagon and somatostatin using RIAs or EIAs. In the
absence of Dox stimulation, no C-peptide, somatostatin or glucagon
was detected. By contrast, all three were detected in supernatants
conditioned by EBs stimulated with Dox (Fig. 4C). We also assessed
the ability of various secretagogues to stimulate secretion of C-
peptide (Fig. 4D). We found that stimulation with 30 mM KCl for
1 hour increased C-peptide secretion about 5-fold. Similarly,
forskolin and IBMX, which increase intracellular cAMP levels,
also increased C-peptide secretion approximately 2-fold and 3-fold,
respectively. On the other hand, we detected no response to glucose
or to the KATP channel inhibitors glibenclamide and tolbutamide
(data not shown). This suggests that whereas pancreatic EBs
inducedbyPdx1andNgn3 arecapable ofrespondingto stimuli that
evoke secretion directly (i.e., membrane depolarization or an
increase in intracellular cAMP), they lack the machinery to respond
to glucose or a KATP channel inhibitor.
Immunohistochemical analysis of pancreas-related
proteins
We next carried out an immunohistochemical analysis to
evaluate protein expression in EBs in which Pdx1 and Ngn3 were
Figure 4. Deletion of N2 and RA supplements increases Ins1 expression. Tet-pdx1/ngn3 ES cells were cultured with Dox (Dox
+) or without
(Dox
2) according to Protocol #3, including B27 supplement formulated with or without RA as indicated. (A) N2 supplement was added to the
indicated groups from the beginning through day 14. B27(+RA), indicated by ‘‘+’’, or B27(2RA), indicated by ‘‘2’’, was included as a supplement from
either day 0–4 or from day 4–14 as indicated. Ins1 mRNA levels at day 14 were quantified by real time PCR and normalized to bTC6 levels. (B) Tet-
pdx1/ngn3 ES cells were cultured with Dox (Dox
+) or without (Dox
2) according to Protocol #3 for 18 days. EBs were trypsinized to make single cell
suspensions and cytoplasmic insulin was detected by immunostaining and analyzed by FACS. (C) EBs were cultured according to Protocol #3 for 18
days with or without Dox, after which the media was replaced with fresh medium for 24 hours and supernatants were harvested. C-peptide,
glucagon and somatostatin were measured by either RIA (C-peptide) or EIA (glucagon, somatostatin) as described in Materials & Methods. (D) EBs
cultured according to Protocol #3 for 19 days were resuspended in HKRB buffer and stimulated with KCl (30 mM), Forskolin (10 M) or IBMX (0.5 mM)
for 1 hour. Supernatants were harvested and C-peptide was measured by RIA. For the Dox
2 samples in panels C & D, C-peptide and somatostatin
values were not detectable above background. The data presented are mean of three independent experiments; the error bars represent the SEM.
*p,0.05 as compared with Dox (2), **p,0.05 as compared with Dox(+).
doi:10.1371/journal.pone.0024058.g004
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Protocol #3, with or without Dox, and then replated on glass
bottom dishes coated with Matrigel. On day 18, the EBs were
immunostained and examined using confocal microscopy. We
found that insulin, C-peptide, Chga and Pcsk2 proteins are all
expressed in Dox-stimulated EBs (Fig. 5), whereas no staining is
detected in EBs not stimulated with Dox (data not shown).
Importantly, most insulin-positive cells co-expressed C-peptide. As
positive controls, we also stained for Pdx1 and Ngn3 after Dox
stimulation (Fig. 5). Our results suggest that the temporal
upregulation of Pdx1 and Ngn3 induces endocrine pancreas cells
that produce bcell-related proteins. The fact that detecting insulin
protein and C-peptide was dependent on Dox-regulation indicates
that these results are detecting endogenously produced insulin and
are not subject to previous published insulin artifacts [30].
Removal of B27 from DMEM enhances pancreatic
differentiation
After culturing tet-pdx1/ngn3 ES cells under Protocol #3 for 6
days, we cultured the cells for the next 12 days according to
Protocol #3 or a modified Protocol #3 in which the IMDM/F12
was replaced with DMEM (Protocol #4). We found that levels of
Ins1 mRNA were higher in the group that contained DMEM
instead of IMDM (Fig. 6A). Moreover, using different concentra-
tions of B27(2RA) according to Protocol #4 revealed that
eliminating B27(2RA) after day6 resulted in an increased Ins1
expression that reached 66% of bTC6 levels on day 18 (Fig. 6B).
Ins1 mRNA ultimately reached 100% of the level in bTC6 cells by
day 26 (Fig. 6C). Immunostaining showed that there was a higher
fraction of cells positive for both insulin and C-peptide when cells
were cultured according to Protocol #4, without B27(2RA) after
day6, compared to Protocol #3 (compare Fig. 6D with Fig. 5).
Using FACS analyses, we also confirmed that 43% of cells from
Dox-stimulated EBs cultured under Protocol #4, without B27,
showed cytoplasmic insulin (Fig. 6E), whereas only 1.0% of EBs
cultured in the absence of Dox were insulin-positive (data not
shown). Under these conditions the 24 hour secretion of C-peptide
increased approximately 4-fold and 10-fold on days 18 and 26,
respectively, as compared to Protocol #3 (compare Fig. 6F with
Fig. 4C). Although these conditions resulted in very high Ins
transcription levels and frequency of insulin positive cells, this
increased level of C-peptide secretion was still less than 1% of the
level of C-peptide secreted from bTC6 cells, which was
3766682 ng/mg protein/24 hour (data not shown). Under these
conditions, tolbutamide significantly increased C-peptide secretion
measured at one hour of stimulation, whereas high glucose did not
(Fig. 6G).
Discussion
Efficient endodermal differentiation is a critical first step in
pancreatic development, since the pancreas is an endoderm-
derived tissue. We previously established two types of differenti-
ation protocols for generating definitive endoderm from ES cells
[21,22]. We show here the utility of temporally upregulating the
expression of Pdx1 and Ngn3, which are known to be important
for pancreatic development, can induce at high frequency the
differentiation of endodermal cells into b-islet cells that transcribe
insulin at high levels, and that these cells secrete C-peptide,
respond to insulin secretagogues, but do not respond to glucose.
When Pdx1 is upregulated after the induction of endoderm
differentiation, the transcription of both Ins1 and Ins2 increased,
and when both and Pdx1 and Ngn3 were co-expressed, Ins1 and
Ins2 transcription was upregulated to a significantly greater extent,
reaching maximal levels in half the time. These results are
consistent with a large body of evidence of the importance of Pdx1
and Ngn3 expression for the normal development of b-islet cell
function and insulin expression. Pdx1 is first expressed in the
pancreatic bud of the gut tube [10,12]. All pancreatic cell types are
derived from Pdx1-positive progenitors [16], and Pdx1 is required
for Ins transcription [10,31,32]. Previous reports have shown that
Ngn3 is expressed in the embryonic pancreas at E10.5, and mice
lacking Ngn3 fail to generate pancreatic endocrine cells [15]. In
addition, cell tracking experiments showed that all b-islet cells are
derived from precursors that express Pdx1 before they express
Ngn3 [16,33], and that the four types of islet endocrine cells are
derived from Ngn3-positive precursors [16]. These results suggest
that Pdx1 is involved in the induction of endoderm to a pancreatic
fate, after which Ngn3 induces the specification and differentiation
of pancreatic endocrine cells from pancreatic primordium, and
Pdx1 continues to be required for insulin expression and normal b-
islet cell function. Moreover, expression of Pdx1 and Ngn3 was
recently reported to be key events in b-islet cell regeneration from
pancreatic duct cells in vivo [34]. These results, together with the
Figure 5. Endocrine protein expression in pancreatic EBs
induced by Pdx1 and Ngn3. Tet-pdx1/ngn3 ES cells were cultured
according to Protocol #3. At day 16, EBs were replated on glass bottom
dishes coated with Matrigel. Replated EBs were stained with antibodies
for the indicated markers of endocrine cells. Insulin was visualized with
a Cy3-conjugated 2
nd–stage fluorescent antibody (red) and other
markers were visualized with a FITC-conjugated 2
nd–stage fluorescent
antibody (green). Nuclei were stained with DAPI (blue). Magnification of
right panel for C-peptide and insulin was with a 10006 objective.
Magnification for the other panels was with a 4006objective.
doi:10.1371/journal.pone.0024058.g005
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24058Figure 6. DMEM media improves pancreatic differentiation of mouse ES cells. Tet-pdx1/ngn3 ES cells were cultured under Protocol #3 for
6 days, with Dox-induction of Pdx1 and Ngn3 expression starting at day 4. A) From day 6 through day 18 EBs were cultured according to Protocol #3
(‘‘IMDM/F12’’) or in medium in which the IMDM/F12 was replaced with DMEM (‘‘DMEM’’) as indicated (Protocol #4), and Ins1 mRNA was quantitated
at day 18. B) EBs were cultured according to Protocol #4 for the first 6 days and with Dox-induction of Pdx1 and Ngn3 expression starting at day 4.
From day 6 through day 18 various concentrations of B27(2RA) were added as indicated. Ins1 mRNA was quantitated at day 18. C) EBs were cultured
according to Protocol #4 for 6 days, with Dox-induction of Pdx1 and Ngn3 expression starting at day 4. From day 6 through day 26 the medium was
only DMEM with BSA without B27(2RA). Ins1 mRNA was quantitated from day 13–26. (D–G) Tet-pdx1/ngn3 ES cells were cultured according to
Protocol #4 for 24 days with Dox induction starting at day 4. D) EBs were replated at day 24 and cultured in DMEM (BSA). At day 26, Insulin was
visualized with a Cy3-conjugated 2
nd antibody (red) and C-peptide was visualized with a FITC-conjugated 2nd antibody (green). Nuclei were stained
with DAPI (blue). Magnification was with a 4006objective. E) EBs, prepared as in panel D, were trypsinized to make single cell suspensions and
cytoplasmic insulin was stained and analyzed by FACS. F) EBs were cultured under Protocol #4 for 6 days, with Dox-induction of Pdx1 and Ngn3
expression starting at day 4. From day 6 through day 18 only one group was supplemented with B27(2RA) (1%) as indicated. On either day 18 or day
26 the media was replaced with fresh DMEM with BSA. Supernatants were harvested after 24 hours, and C-peptide was measured by RIA. The data
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important for fetal islet development, adult islet regeneration, and
ES cell-derived pancreatic differentiation.
To optimize the conditions that promote ES-derived pancreatic
differentiation, we evaluated Protocol #2. Gouon-Evans et al.
originally developed this protocol (‘‘SFD’’) for mouse ES-derived
hepatocyte differentiation and showed that BMP4 is required for
hepatic differentiation under this protocol [22]. It is important to
note that all of the protocols we have studied require activin to
initiate high efficiency generation of endoderm. Here we
demonstrate that exogenous BMP4 improves mouse ES-derived
pancreatic differentiation and increases Ins1 mRNA levels. BMP4
also reportedly promotes the proliferation and development of
epithelial islet-like structures and pancreatic progenitor cells in vitro
[35,36]. The recent work of Wandzioch and Zaret also actually
shows that in the mouse embryo, BMP is required at a later time
point for pancreas specification compared to liver specification
[28]. In the present study, we found that changes to the Protocol
#2 culture medium, namely adding BMP4, using DMEM instead
of IMDM/F12, eliminating the N2 and B27 supplements,
culturing the cells in 3D non-adherent structures, i.e. Protocol
#4, dramatically increased Ins1 mRNA levels up to 100% of the
normalized values seen in bTC6 insulinoma cell line. Under these
conditions, although the EB size was smaller than observed with
Protocol #2, the relative number of insulin positive cells increased.
This suggests that Protocol #4 provides a relative enrichment for
insulin-positive cells. EBs induced toward pancreatic differentia-
tion by the above protocols express a variety of pancreas-related
proteins detected immunohistochemically, including Chga, Pcsk2,
plus fully processed insulin and C-peptide. In addition, insulin was
processed and C-peptide was secreted into the supernatant. This
suggests that Pdx1 and Ngn3 induce efficient differentiation of
functional islet-like cells from ES cell-derived endoderm and that
the cells are capable of producing and correctly processing insulin.
This in vitro differentiation process mimics embryonic pancreatic
endocrine development, which can be useful for evaluating the
gene expression pattern of pancreatic endocrine cell differentiation
and b-islet cell biology. To evaluate this, we performed microarray
analyses of Pdx1- and Ngn3-induced EB differentiation. Through
these analyses we found that pancreas-related genes encoding
secretory proteins (e.g., Ins and Sst) and transcription factors (e.g.,
Pax6 and neuroD) were induced by Pdx1 and Ngn3 during EB
differentiation. Conversely, genes characteristic of hepatocyte and
intestine were suppressed by Pdx1 and Ngn3. This accurately
reflects the known functional tissue specificity of these genes. In
addition, other genes recently reported to play a role in pancreas
development were also shown to be upregulated in Pdx1- and
Ngn3-induced EBs. For example, cocaine- and amphetamine-
regulated transcript (Cart) is upregulated in our studies and was
recently reported to be expressed in pancreatic b-islet cells and to
enhance insulin secretion from an insulinoma cell line and from
isolated rat islet cells [37,38]. Resp18 is increased 87-fold by
Pdx1/Ngn3 induction in our studies and was also recently
reported to be expressed in pancreatic b-islet cells and markedly
stimulated following exposure to high glucose [39]. We also found
that genes expressed in enteroendocrine cells (e.g., Gip, Cck, Pyy
and Ghrl) were upregulated, suggesting that these genes important
for both enteroendocrine and pancreatic hormones are dependent
on the expression Pdx1 and/or Ngn3.
Consistent with normal b-islet cell biology, direct depolarization
of the ES-derived cells using KCl, or IBMX- or forskolin-induced
intracellular cAMP increase, stimulated C-peptide release from the
ES-derived pancreatic cells during a 1-hour secretion assay. These
combined results indicate that ES-derived pancreatic cells produce
and correctly process insulin and that C-peptide secretion is
regulated by various insulin secretagogues. Despite the fact that
Ins1 mRNA levels were comparable to those found in bTC6 cells
in protocol #4 differentiated cells, C-peptide secretion was not
glucose responsive and was only 0.75% of the normalized levels
observed in bTC6 cells. Apparently, the current protocol does not
induce at high efficiency the final maturation steps that result in
adult-level glucose responsiveness. By using various growth factors
at each differentiation step, D’Amour et al. were able to
differentiate insulin-expressing cells from human ES cells [24]
that could respond to glucose in vivo and could be used to
successfully treat diabetic mice, suggesting that they were
functionally glucose responsive [40]. It is not clear from
D’Amour’s studies if the b-islet cells were glucose responsive in
vitro prior to transplantation in vivo. It is possible that in vivo
conditions are required for the final maturation steps leading to
fully mature functional properties, which are not yet replicated in
our culture systems. The identification of the potential biological
factors and/or cellular interactions that are required for final b-
islet cell maturation and full glucose responsiveness remains an
elusive problem and as yet not replicated in vitro.
In conclusion, we have shown that mouse ES cells can be
induced by activin to differentiate into definitive endoderm,
followed by differentiation to pancreatic endocrine cells through
subsequent stimulation of BMP4 and overexpression of Pdx1 and
Ngn3. During this differentiation scheme, many gene expression
cascades that mimic embryonic pancreatic development are
expressed in an appropriate temporal order, suggesting this in
vitro model may be useful as a screen for evaluating potential genes,
or drug candidates, that induce or increase pancreatic endocrine
cell differentiation. In addition, it is clear that further work is
necessary to define the requirement for efficient and reproducible
induction of full b-islet cell maturation and glucose responsiveness
in vitro. These studies also highlight some of the limitations of
current differentiation protocols as well as offer improved
protocols that dramatically improve the frequency and level of
insulin expression. These studies further support the view that ES
cells, and iPS by extension, have the potential to be a renewable
resource for producing b-islet cells for cell-based diabetes therapy.
Methods
Growth and Differentiation of ES cells
We used Ainv 18 mouse ES cells (a kind gift from Drs. Michael
Kyba and George Daley; ATCC SCRC-1029) to assess gene
function during ES cell differentiation to pancreatic lineages [41].
These cells were engineered to allow ‘‘cre-lox’’ targeted insertion
of ‘‘tet-on’’ expression cassettes into the hprt locus. This system
enables the efficient temporal upregulation of target genes by the
addition of Dox (Sigma, St. Louis). For some experiments, the bi-
cistronic expression of two target genes was achieved through the
presented are mean of three independent experiments; the error bars represent the SEM. p,0.05 as compared with 1% B27 at day 18. G) EBs were
prepared as described in panel F. On day 26 the media was replaced with HKRB buffer containing either low glucose media (2 mM) or high glucose
media (20 mM) with or without tolbutamide. Supernatants were harvested after 1 hour and C-peptide was measured by RIA. The data presented are
mean of three independent experiments; the error bars represent the SEM. p,0.05 as compared with low glucose without tolbutamide.
doi:10.1371/journal.pone.0024058.g006
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ngn3 pLOX expression vectors were electroporated, together with
a cre expression construct [43], into Ainv 18 ES cells according to
published procedures (Amaxa, Lonza, AG). This yielded ‘‘tet-
pdx1’’ or ‘‘tet-pdx1/ngn3’’ ES cells, which could be induced by
Dox to express Pdx1 or both Pdx1 and Ngn3, respectively. ES cells
were maintained on irradiated mouse embryo fibroblast feeder
cells as previously described [21]. To generate EBs, ES cells were
passaged two times on gelatin, dissociated into a suspension of
single cells using trypsin (0.25%), and then cultured at various
concentrations in 60 mm bacterial-grade petri dishes (Valmark) in
differentiation media, as described below. Cultures were main-
tained in a humidified chamber under a 5% CO2-air mixture at
37uC.
Four protocols were evaluated for differentiation of pancreas-
like cells (see details in Supplemental Table S1). The first protocol
utilized activin-mediated induction of endoderm via a two-step
endoderm Protocol #1 (‘‘SP protocol’’) as previously described
[21]. Dissociated undifferentiated ES cells (4610
3 cells/ml) were
cultured for 2 days in suspension in Stem Pro 34 medium (Gibco)
supplemented with 2 mM glutamine, 0.5 mM ascorbic acid,
4.5610
24 M monothioglycerol (MTG) and c-kit ligand (1%
conditioned medium from CHO cells). EBs were harvested after
48 hours of differentiation, allowed to settle in a 50 ml tube,
transferred to new petri dishes (Valmark) and cultured for 4 days
in IMDM supplemented with 15% Knockout serum replacement
(SR) (Gibco), 2 mM glutamine, 0.5 mM ascorbic acid,
4.5610
24 M MTG and human activin A (100 ng/ml) (R&D
Systems). To induce test genes, starting on day 6 after EB
formation, Dox (1 mg/ml) was included in IMDM supplemented
with 15% SR, 2 mM glutamine, 0.5 mM ascorbic acid, and
4.5610
24 M MTG. After differentiation for 10 days from the start
of differentiation, the EBs were transferred to Matrigel-coated 6-
well dishes (Falcon) in IMDM supplemented with 15% fetal calf
serum (FCS; JRH) and 2 mM glutamine, with or without Dox
(1 mg/ml). Cells from these replated cultures were harvested for
RNA isolation at the indicated times from the start of initial
differentiation.
Protocol #2 used serum-free differentiation medium, as
previously described (‘‘SFD protocol’’) [22], that contains 75%
IMDM and 25% Ham’s F12 medium (Gibco) supplemented with
0.5% N2 and 1% B27 (with vitamin A/retinoic acid, ‘‘RA’’)
(Gibco), 1% penicillin/streptomycin, 0.05% bovine serum albu-
min, 2 mM glutamine, 0.5 mM ascorbic acid and 4.5610
24 M
MTG. ES cells (2–4610
4 cells/ml) were cultured in this medium
in 60 mm low attachment petri dishes. On day 2 of differentiation,
EBs were dissociated with trypsin/EDTA and replated at a density
of 2–6610
4 cells/ml in new 60 mm petri dishes using Protocol #2
medium supplemented with activin A (50 ng/ml). On day 4, EBs
were dissociated with trypsin/EDTA and then reaggregated at
high density (5610
5 cells/ml) in 24-well low-cluster dishes (Nunc)
in Protocol #2 medium supplemented with BMP4 (50 ng/ml)
(R&D Systems), bFGF (10 ng/ml) (R&D Systems) and activin A
(50 ng/ml), with or without Dox (1 mg/ml). On day 6, EBs were
replated on gelatin coated 6-well dishes (Falcon) for monolayer
culture or in 12-well low-cluster dishes (Nunc) to obtain non-
adherent floating EBs in Protocol #2 medium, with N2 and/or
B27(+RA), without either ascorbic acid or MTG, and with or
without Dox (1 mg/ml). Protocol #3 was identical to Protocol #2
except B27 did not contain RA, media was not supplemented with
N2, and after day 6 the cells were cultured in low-cluster dishes to
obtain non-adherent floating EBs. Protocol #4 was identical to
Protocol #3 except DMEM was used instead of IMDM/F12
media.
PCR Gene expression analysis
For RT-PCR, total RNA was extracted using RNeasy mini-kits
and treated with RNase-free DNase (Qiagen). One mg of total
RNA was reverse-transcribed to cDNA using a Superscript RT kit
(Invitrogen) with random hexamers. PCR was carried out using
Taq polymerase (Takara Bio) in PCR buffer containing 2.5 mM
MgCl2 and 0.2 mM dNTPs. The amplification protocol was 1
cycle at 94uC for 5 min followed by 25–40 cycles of 94uC for
1 min (denaturation), 60uC for 30 sec (annealing) and 72uC for
1 min (elongation), with a final elongation at 72uC for 7 min. The
oligonucleotide primers used for PCR are listed in supplemental
Table S2.
For quantitative real-time PCR, commercially available assay
mixes (Applied Biosystems) for Ins1 (Mm01259683_g1), Ins2
(Mm00731595_gH) and 18S (Hs99999901_s1) were used to
quantify mRNA levels, and PCR was performed using a Prism
7700 Sequence Detector (Applied Biosystems). Ins1 and Ins2
mRNA levels were normalized to 18S mRNA levels in the same
samples, expressed as Ins/18S ratios, and plotted as percentages of
the Ins/18S ratios observed in bTC6 cells grown in 15%FCS
DMEM and harvested in log phase. All experiments repeated at
least two times.
Transient gene upregulation mediated by vector
electroporation
Pax4, Nkx6.1 and Ngn3 coding regions were cloned downstream
of the CMV promoter in the pIRES-EGFP vector (Clontech). Tet-
pdx1 or tet-pdx1/ngn3 ES cells were cultured under Protocol #1.
On day 6, EBs were dissociated with trypsin/EDTA (0.25%), after
which the resultant cells (1–3610
6 cells) were suspended in mouse
ES cell nucleofection solution (Amaxa). Gene expression plasmids
(5 mg) were electroporated into cells using an Amaxa Nucleofector
device (ES solution, program O-17). The cells were then washed
and reaggregated in 24-well low-cluster dishes (Costar) in IMDM
supplemented with 15% SR (Gibco), 2 mM glutamine, 0.5 mM
ascorbic acid and 4.5610
24 M MTG containing Dox (1 mg/ml).
EBs were harvested on day 8 for FACS or on day 9 for RNA
isolation.
Microarray analysis
For microarray analysis, total RNA was extracted using RNeasy
mini kits (Qiagen), after which 10-mg samples of fragmented target
total RNA was used for hybridization of CodeLink Mouse Whole
Genome Arrays (GE Life Sciences), which contained 34,967
probes. Once the microarrays were hybridized and washed, biotin-
containing transcripts were directly detected using a Streptavidin-
Alexa647 conjugate as previously described [44]. GeneSpring 7
(Silicon Genetics, Inc., Redwood City, CA) was then used to
evaluate the data obtained using CodeLink
TM Expression
Scanning Software. Because some CodeLink probes are improp-
erly annotated as to their intended target, refinement of gene-to-
probe associations was accomplished by analysis using VistaGen’s
Valid Probe Set tools, which results from a mapping of the
genomic coordinates of probes with that of the exons of genes. All
genomic coordinates of the mouse genome were determined using
BLAST. Invalid probes, such as those that target multiple genes,
non-coding strand, or intergenic regions on the genome, were
removed from analyses.
FACS analysis and cell sorting
We used our previously published methods to isolate definitive
endoderm populations [22,45]. Day 4 EBs were trypsinized for
single cell suspension, then stained with a PE-conjugated anti-c-kit
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anti-mouse CXCR4 antibody (BD Pharmingen, 551968, 1/200),
and visualized using streptoavidin PE-Cy5 (BD Pharmingen).
Cytoplasmic insulin was detected in cells from day 18 EBs
dissociated with 0.25% trypsin/EDTA and 0.05% collagenase,
stained with a guinea pig anti-insulin antibody (Dako, A0564 1/
100), and visualized using a PE-conjugated anti-guinea pig IgG
secondary antibody (Jackson Immunoresearch) with the Cytofix/
Cytoperm kit (Becton Dickenson) according to manufacturer’s
recommendations. The stained cells were also analyzed using a
FACScan (Becton Dickinson, San Jose, CA) or sorted on a FACS
Aria cell sorter (Becton Dickinson). All experiments repeated at
least two times.
Immunostaining
For immunostaining, day 16 EBs were plated on glass bottom
dishes (Matek) coated with Matrigel. Two days later, the day 18
EBs were fixed in 4% paraformaldehyde for 20 min, washed two
times in PBS, permeabilized in PBS containing 0.2% triton-6100,
washed in PBS containing 10% FCS and 0.2% Tween 20, and
then blocked for 10 min in PBS containing 10% horse serum. The
cells were then incubated for 1 hour with a primary antibody
specific for either insulin (Dako, A0564, 1/150), C-peptide
(Yanaihara, Y222, 1/100), Pdx1 (Transgenic, KR059, 1/100),
Ngn3 (Santa Cruz sc-25655, 1/50), Pcsk2 (Chemicon, AB1262, 1/
100) or Chga (Epitomics, #1782-1, 1/100), and visualized using a
Cy3-conjugated anti-guinea pig IgG secondary antibody or FITC-
conjugated anti-rabbit IgG secondary antibody (Jackson Immu-
noresearch, 1/200) as appropriate. After the second staining step,
the EBs were washed and covered with antifade reagent
containing DAPI (Molecular Probe). Images were then captured
using a FLUOVIEW FV1000 confocal microscope (Olympus)
with 106,4 0 6and 1006objectives. All experiments repeated at
least two times.
Measurement of C-peptide, glucagon and somatostatin
secretion from EBs
After culturing EBs for 17–18 days in Protocol #3 medium,
with or without Dox (1 mg/ml), the medium was changed to fresh
IMDM/F12/BSA/B27(2RA) media, with 2 mM glutamine and
no growth factors. The EBs were then incubated for 24 hours as
indicated, after which the conditioned medium was collected for
secretion assays. Concentrations of glucagon and somatostatin in
the conditioned medium were measured using enzyme immuno-
assays (EIAs) specific for glucagon (Yanaihara) or somatostatin
(Phoenix Pharmaceuticals) according to the manufacturer’s
instructions. To assay C-peptide secretion, day 18 EBs were
washed and then incubated for 1 hour in Krebs-Ringer bicar-
bonate HEPES buffer (2 mM glucose) with or without stimulation
with secretagogues. C-peptide in the supernatant was then
measured using a specific radioimmunoassay (RIA; Linco). The
amount of protein in each sample was determined using BCA
assays (Pierce), and measured levels of secreted C-peptide,
glucagon and somatostatin were normalized to the total protein.
Supporting Information
Figure S1 Time course of pancreatic gene expression.
Tet-pdx1/ngn3 ES cells were cultured according to Protocol #2w i t h
BMP4 and cultured in suspension. Pdx1 and Ngn3 wereinducedwith or
without Dox starting at day 4, and cells were harvested at the indicated
time points. Various pancreatic related-genes were analyzed by
microarrays. Dox(2); open squares, Dox(+); closed circles.
(TIF)
Table S1 Protocol for culture conditions.
(RTF)
Table S2 Oligonucleotide primers used for PCR.
(RTF)
Table S3 Microarray gene expression analysis. Tet-
pdx1/ngn3 ES cells were cultured according to Protocol #2 with
BMP4 and cultured in suspension. Pdx1 and Ngn3 were induced
with or without Dox starting at day 4, and cells were harvested at
the indicated time points. RNA samples were isolated from day 13
EBs with or without Dox, bTC6 cells and e15.5 mouse embryo
and various pancreatic related-genes were analyzed by micro-
arrays.
(RTF)
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